Table 5.
Age and histological results among hr-HPV-positive/cytology-negative women
| AGE | Histological Results | |||||
|---|---|---|---|---|---|---|
| TOTAL | NORMAL(n,%) | LSIL(n,%) | HSIL(n,%) | CA(n,%) | HSIL+(n,%) | |
| <30 | 992 | 565 (56.96) | 181 (18.25) | 241 (24.29) | 5 (0.50) | 246 (24.80) |
| 31–40 | 2140 | 1249 (58.36) | 418 (19.53) | 453 (21.17) | 20 (0.93) | 473 (22.10) |
| 41–50 | 1868 | 1117 (59.80) | 385 (20.61) | 341 (18.25) | 25 (1.34) | 336 (19.59) |
| 51–60 | 182 | 120 (65.93) | 36 (19.78) | 21 (11.54) | 5 (2.75) | 26 (14.29) |
| >60 | 698 | 475 (68.05) | 135 (19.34) | 80 (11.46) | 8 (1.15) | 88 (12.61) |
| Na | 5880 | 3526 (59.97) | 1155 (19.64) | 1136 (19.32) | 63 (1.07) | 1199 (20.39) |
HPV human papillomavirus
hr-HPV high-risk human papillomavirus
LSIL low-grade squamous intraepithelial lesion
HSIL high-grade squamous intraepithelial lesion
CA cervical cancer
HSIL+ high-grade squamous intraepithelial lesion and cervical cancer
a=The total number of people with different ages in the corresponding histological results groups